📰 Alkermes News
Page 30 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
June 17, 2023
Alkermes plc (NASDAQ:ALKS – Get Rating) has been assigned a consensus rating of “Hold” from the five research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among analysts […]
June 17, 2023
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $1.34-$1.57 for the period, compared to the consensus estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Wall Street Analysts Forecast […]
June 16, 2023
This Mens Health Week, Alkermes is shining a light on some of the unique health risks that may affect men related to mental health and excessive al
June 16, 2023
Alkermes plc (NASDAQ:ALKS – Get Rating) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $32.34 and last traded at $32.01, with a volume of 302433 shares traded. The stock had previously closed at $31.93. Wall Street Analysts Forecast Growth Several brokerages have recently issued reports […]
June 16, 2023
/PRNewswire/ -- The "Extended Release Injectable Drugs" report has been added to ResearchAndMarkets.coms offering. Chronic conditions require drug...
June 16, 2023
Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.
June 15, 2023
Sarissa believes Chairman and CEO Richard Pops wants to prevent accountability and oversight that would come from Sarissa representation on the Alkermes board Sarissa believes Chairman and CEO... | June 15, 2023
June 15, 2023
Auxier Asset Management reduced its stake in Alkermes plc (NASDAQ:ALKS – Get Rating) by 8.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,541 shares of the company’s stock after selling 1,200 shares during the period. Auxier Asset Management’s holdings in […]
June 15, 2023
Proxy advisory firm Institutional Shareholder Services on Thursday recommended that Biogen shareholders elect Susan Langer to replace long-standing director Alex Denner, who abruptly left the board earlier this week. Biogen said Langer, a former corporate strategy chief at the biotech company, would stand for election to replace Denner. ISS issued its recommendation after the unexpected announcement on Monday that three directors -- Denner, William Jones and Richard Mulligan -- would not stan...
June 15, 2023
Proxy advisory firm Institutional Shareholder Services on Thursday recommended that Biogen shareholders elect Susan Langer to replace long-standing director Alex Denner, who abruptly left the... | June 16, 2023